The Centers for Disease Control and Prevention's vaccine advisory panel met Thursday for the first of two days of discussions about childhood vaccine schedules and recommendations. The panel is focusing on the hepatitis B vaccine and plans to vote on whether to continue recommending it be given to all children at birth or delay the first dose.

However, that vote was postponed until Friday amid confusion on the exact wording of the questions the committee was set to vote on.

The hepatitis B vaccine has been universally recommended for newborns in the U.S. since 1991. Since then, research shows hepatitis B infections among infants and children have dropped 99%.

Hepatitis B is an incurable infection that can lead to liver disease, cancer and early death.

The shot has become a ta

See Full Page